5.24
-0.16
(-2.96%)
At close: January 31 at 4:00:02 PM EST
5.59
+0.35
+(6.68%)
After hours: January 31 at 5:05:35 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BRADY TODD C Chief Executive Officer | Sale | Mar 12, 2024 | 1,471,300 |
| BRONSTEIN BEN Director | Conversion of Exercise of derivative security | Jun 27, 2023 | 28,248 |
| GREENBERG BRUCE Chief Financial Officer | Sale | Aug 12, 2024 | 126,382 |
| MACHATHA STEPHEN Officer | Sale | Aug 12, 2024 | 236,771 |
| MILLER-RICH NANCY Director | Purchase | Apr 12, 2023 | 922 |
| PERCEPTIVE ADVISORS L L C Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 5, 2024 | -- |
| PHILLIPS GARY M Director | Conversion of Exercise of derivative security | Sep 7, 2023 | 14,812 |
| WALKER NEAL Director | Conversion of Exercise of derivative security | Aug 22, 2023 | 15,854 |
Related Tickers
ABEO Abeona Therapeutics Inc.
5.54
+1.28%
MIST Milestone Pharmaceuticals Inc.
1.9700
-2.48%
URGN UroGen Pharma Ltd.
11.01
-3.00%
ARDX Ardelyx, Inc.
5.36
0.00%
SCPH scPharmaceuticals Inc.
3.3200
-3.77%
MGTX MeiraGTx Holdings plc
6.29
-2.18%
VNDA Vanda Pharmaceuticals Inc.
4.4100
-3.71%
KALA KALA BIO, Inc.
9.20
-2.95%
CAPR Capricor Therapeutics, Inc.
15.04
-1.05%
PLX Protalix BioTherapeutics, Inc.
2.4300
+2.10%